Table 3.
Delivery system | Cargo options | Advantages | Disadvantages |
---|---|---|---|
Lipid nanoparticles |
RNP plasmid DNA RNP complex Cas9 mRNA sgRNA Donor DNA |
High biocompatibility Low immunogenicity Reduce off-target effects Can be mass produced Low cost |
Degradation in vivo |
Polymer nanoparticles |
RNP plasmid DNA RNP complex Cas9 mRNA sgRNA Donor DNA |
High biocompatibility Low immunogenicity Reduce off-target effects Can be mass produced Low cost |
Toxicity Limited delivery efficiency |
Golden nanoparticles |
RNP plasmid DNA RNP complex Cas9 mRNA sgRNA Donor DNA |
High biocompatibility Low immunogenicity Reduce off-target effects Can be mass produced Low cost |
Limited delivery efficiency |